日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis.

用于治疗抗NMDA受体脑炎的单克隆人源化单价抗体阻断疗法

Kanno Atsuo, Kito Takuya, Maeda Masashi, Yamaki Shanni, Amano Yasushi, Shimomura Takuya, Anisimova Margarita, Kanazawa Naomi, Suzuki Koichiro, Razai Amir, Mihara Takuma, Kubo Kaori, Shimada Takeshi, Nakamura Koji, Nomura Naoko, Kondo Yuji, Okimoto Akira, Sugiyama Azusa, Park Deborah, Stein Ivar, Petshow Samuel, Vandendoren Valentin, Bilic Sanela, Kazimi Roghiye, Eastman Vallari, Snipas Scott J, Mitchell Mathew, Maurer Mari, Jefson Marty, Lichter Jay, Yamajuku Daisuke, Shirai Hiroki, Adachi Megumi, Hoeppner Daniel J, Kubo Satoshi, Zito Karen, Iizuka Takahiro, Flynn Peter, Matsumoto Mitsuyuki

Nociceptive afferent phenotyping reveals that transient receptor potential ankyrin 1 promotes cold pain through neurogenic inflammation upstream of the neurotrophic factor receptor GFRα3 and the menthol receptor transient receptor potential melastatin 8

伤害性传入神经表型分析表明,瞬时受体电位锚蛋白1通过神经营养因子受体GFRα3和薄荷醇受体瞬时受体电位melastatin 8上游的神经源性炎症促进冷痛。

Yamaki, Shanni; Chau, Amanda; Gonzales, Luigi; McKemy, David D